Incremental Vestibulo-ocular Reflex Adaptation As a Novel Treatment for Dizziness in People with Multiple Sclerosis

Last updated: March 25, 2025
Sponsor: Emory University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Multiple Sclerosis

Dizzy/fainting Spells

Low Blood Pressure (Hypotension)

Treatment

StableEyes

Clinical Study ID

NCT06495138
STUDY00007558
RG-2307-41945
  • Ages 18-89
  • All Genders

Study Summary

The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MSper the 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging inMS

  • Fluent in speaking and understanding English

  • Have self-reported vestibular symptoms of dizziness, imbalance, and/or a history ofat least two falls in the prior 12 months

Exclusion

Exclusion Criteria:

  • Clinically isolated syndrome or radiologically isolated syndrome.

  • Worsening MS symptoms during the prior 60 days

  • Immunotherapy change in the prior 60 days

  • Self-reported cognitive impairment that limits independence with basic andinstrumental activities of daily living

  • Systolic blood pressure > 180 mmHg and/or diastolic blood pressure > 90 mmHg at rest

  • Static visual acuity with correction of worse than 1.0 logMAR

  • Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus}

  • Convergence insufficiency

  • Intra-nuclear ophthalmoplegia

  • Benign paroxysmal positional vertigo

  • Major orthopedic conditions that limit cervical spine range of motion or that alterwalking

  • Self-reported current or potential for pregnancy during enrollment

  • Ongoing participation in vestibular rehabilitation for dizziness

Study Design

Total Participants: 138
Treatment Group(s): 1
Primary Treatment: StableEyes
Phase:
Study Start date:
April 01, 2025
Estimated Completion Date:
March 31, 2027

Study Description

People with multiple sclerosis (MS) often experience dizziness, caused by problems in how their brain processes balance signals. This dizziness can lead to difficulties keeping their eyes focused on a target while moving their head, known as gaze instability. This makes activities like walking or driving challenging and dangerous. Vestibular physical therapy, including gaze stabilization exercises, can help. The team developed StableEyes, a technology that improves gaze stability using a gradual approach to these exercises. In the studies, StableEyes significantly enhanced gaze stability in people with balance issues. Preliminary research in people with MS shows promising results, suggesting that tailored gaze stability exercises can further improve their vision stability. This method targets the vestibulo-ocular reflex (VOR), a critical reflex for maintaining clear vision during head movements. Improved VOR function can reduce dizziness and improve the quality of life for people with MS.

Connect with a study center

  • Emory Univeristy

    Atlanta, Georgia 30329
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.